{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:07:30Z","timestamp":1792951650846,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Basic Project of Shanxi Province, China","award":["20210302124183, 201701D121165, 201901D111190"],"award-info":[{"award-number":["20210302124183, 201701D121165, 201901D111190"]}]},{"name":"Open Fund from Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, China","award":["KLMEC\/SXMU-202011"],"award-info":[{"award-number":["KLMEC\/SXMU-202011"]}],"id":[{"id":"https:\/\/ror.org\/0265d1010","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanxi \u20181331 Project\u2019 Key Subjects Construction, China","award":["1331KSC"],"award-info":[{"award-number":["1331KSC"]}]},{"name":"Scientific research project of Shanxi Provincial Health Commission, China","award":["2019059"],"award-info":[{"award-number":["2019059"]}]},{"name":"Research Project Supported by Shanxi Scholarship Council of China","award":["2020-194 and 2021-165"],"award-info":[{"award-number":["2020-194 and 2021-165"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30901821 and 81172136"],"award-info":[{"award-number":["30901821 and 81172136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Foundation of Shanxi Province, China","award":["201901D211547"],"award-info":[{"award-number":["201901D211547"]}]},{"name":"\u201c136\u201d College-level open fund, China","award":["2021YZ03"],"award-info":[{"award-number":["2021YZ03"]}]},{"name":"Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi","award":["2021L339"],"award-info":[{"award-number":["2021L339"]}]},{"name":"Natural Science Foundation for Young Scientists of Shanxi Province, China","award":["201801D221069"],"award-info":[{"award-number":["201801D221069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10637-023-01360-9","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:02:15Z","timestamp":1682380935000},"page":"438-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase"],"prefix":"10.1007","volume":"41","author":[{"given":"Chan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"8","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C (2021) Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med 27(8):1345\u20131356","journal-title":"Nat Med"},{"issue":"5","key":"1360_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","volume":"20","author":"DS Ettinger","year":"2022","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS et al (2022) Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(5):497\u2013530","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1360_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1\u201324","journal-title":"Clin Chest Med"},{"issue":"1","key":"1360_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi S, de Sauvage FJ (2020) The great escape: tumour cell plasticity in resistance to targeted therapy. Nat Rev Drug Discov 19(1):39\u201356","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cancers12020436","volume":"12","author":"J Shen","year":"2020","unstructured":"Shen J, Li L, Yang T, Cohen PS, Sun G (2020) Biphasic mathematical model of cell-drug interaction that separates target-specific and off-target inhibition and suggests potent targeted drug combinations for multi-driver colorectal cancer cells. Cancers (Basel) 12(2):436","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1360_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12185-020-03034-1","volume":"113","author":"L Alkebsi","year":"2021","unstructured":"Alkebsi L, Wang X, Ohkawara H, Fukatsu M, Mori H, Ikezoe T (2021) Dasatinib induces endothelial-to-mesenchymal transition in human vascular-endothelial cells: counteracted by cotreatment with bosutinib. Int J Hematol 113(3):441\u2013455","journal-title":"Int J Hematol"},{"issue":"7","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/abbs\/gmab061","volume":"53","author":"C Liu","year":"2021","unstructured":"Liu C, Zhu X, Jia Y, Chi F, Qin K, Pei J, Zhang C et al (2021) Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt\/mTOR compromises dasatinib as a cancer drug. Acta Biochim Biophys Sin (Shanghai) 53(7):823\u2013836","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-019-1166-3","volume":"38","author":"WC Huang","year":"2019","unstructured":"Huang WC, Kuo KT, Wang CH, Yeh CT, Wang Y (2019) Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src\/CD155\/MIF functional pathway. J Exp Clin Cancer Res 38(1):180","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/cancers12061361","volume":"12","author":"PC Hsu","year":"2020","unstructured":"Hsu PC, Yang CT, Jablons DM, You L (2020) The crosstalk between src and Hippo\/YAP signaling pathways in non-small cell lung cancer (NSCLC). Cancers (Basel) 12(6):1361","journal-title":"Cancers (Basel)"},{"issue":"26","key":"1360_CR10","doi-asserted-by":"publisher","first-page":"E6030","DOI":"10.1073\/pnas.1717782115","volume":"115","author":"PD Fan","year":"2018","unstructured":"Fan PD, Narzisi G, Jayaprakash AD, Venturini E, Robine N, Smibert P, Germer S et al (2018) YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A 115(26):E6030\u2013E6038","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.3390\/cancers12123717","volume":"12","author":"M Fuentes-Baile","year":"2020","unstructured":"Fuentes-Baile M, Ventero MP, Encinar JA, Garc\u00eda-Morales P, Poveda-Deltell M, P\u00e9rez-Valenciano E, Barber\u00e1 VM et al (2020) Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines. Cancers (Basel) 12(12):3717","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1360_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10549-020-05927-5","volume":"185","author":"L Xue","year":"2021","unstructured":"Xue L, Chen F, Yue F, Camacho L, Kothapalli S, Wei G, Huang S et al (2021) Metformin and an insulin\/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer. Breast Cancer Res Treat 185(1):73\u201384","journal-title":"Breast Cancer Res Treat"},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"118977","DOI":"10.1016\/j.lfs.2020.118977","volume":"267","author":"B Zeng","year":"2021","unstructured":"Zeng B, Liao X, Liu L, Zhang C, Ruan H, Yang B (2021) Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1\/PI3K\/AKT signaling pathway. Life Sci 267:118977","journal-title":"Life Sci"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13104-016-1919-4","volume":"9","author":"SE Franks","year":"2016","unstructured":"Franks SE, Jones RA, Briah R, Murray P, Moorehead RA (2016) BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549. BMC Res Notes 9:134","journal-title":"BMC Res Notes"},{"issue":"5","key":"1360_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cellbi.2006.11.017","volume":"31","author":"AQ Dong","year":"2007","unstructured":"Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH (2007) Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 31(5):500\u2013507","journal-title":"Cell Biol Int"},{"issue":"6","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.humpath.2014.01.010","volume":"45","author":"N Reinmuth","year":"2014","unstructured":"Reinmuth N, Kloos S, Warth A, Risch A, Muley T, Hoffmann H, Thomas M et al (2014) Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer. Hum Pathol 45(6):1162\u20131168","journal-title":"Hum Pathol"},{"issue":"1","key":"1360_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-11-0022","volume":"47","author":"K Siddle","year":"2011","unstructured":"Siddle K (2011) Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol 47(1):R1\u201310","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"1360_CR18","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1038\/s41598-021-90289-1","volume":"11","author":"CE Lehman","year":"2021","unstructured":"Lehman CE, Spencer A, Hall S, Shaw JJP, Wulfkuhle J, Petricoin EF, Bekiranov S et al (2021) IGF1R and src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK. Sci Rep 11(1):10826","journal-title":"Sci Rep"},{"issue":"3","key":"1360_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/molecules24030623","volume":"24","author":"J Shen","year":"2019","unstructured":"Shen J, Li L, Yang T, Cheng N, Sun G (2019) Drug sensitivity screening and targeted pathway analysis reveal a multi-driver proliferative mechanism and suggest a strategy of combination targeted therapy for colorectal cancer cells. Molecules 24(3):623","journal-title":"Molecules"},{"issue":"12","key":"1360_CR20","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1158\/1535-7163.MCT-12-0447","volume":"11","author":"N Awasthi","year":"2012","unstructured":"Awasthi N, Zhang C, Ruan W, Schwarz MA, Schwarz RE (2012) BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor\/insulin receptor, enhances gemcitabine response in pancreatic cancer. Mol Cancer Ther 11(12):2644\u20132653","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jtho.2021.02.010","volume":"16","author":"DR Camidge","year":"2021","unstructured":"Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, Weiss J, Ades S, Shapiro GI et al (2021) Crizotinib in patients with MET-amplified NSCLC. J Thorac Oncol 16(6):1017\u20131029","journal-title":"J Thorac Oncol"},{"issue":"10","key":"1360_CR22","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41419-020-03047-y","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Chen Q, Cheng Z, Gu J, Feng W, Lei T, Huang J et al (2020) Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death Dis 11(10):858","journal-title":"Cell Death Dis"},{"issue":"9","key":"1360_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W et al (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797","journal-title":"Cell Death Dis"},{"issue":"8","key":"1360_CR24","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"Nepstad I, Hatfield KJ, Gr\u00f8nnings\u00e6ter IS, Reikvam H (2020) The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci 21(8):2907","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1360_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan AC (2020) Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer 11(3):511\u2013518","journal-title":"Thorac Cancer"},{"issue":"2","key":"1360_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-012-2376-y","volume":"137","author":"J Bostner","year":"2013","unstructured":"Bostner J, Karlsson E, Pandiyan MJ, Westman H, Skoog L, Fornander T, Nordenskj\u00f6ld B et al (2013) Activation of akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat 137(2):397\u2013406","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1360_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 21(3):1102","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten M, Barbacid M (2020) Targeting the MAPK pathway in KRAS-driven tumors. Cancer Cell 37(4):543\u2013550","journal-title":"Cancer Cell"},{"key":"1360_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2020.03.009","volume":"107","author":"D Mart\u00ednez-Alonso","year":"2020","unstructured":"Mart\u00ednez-Alonso D, Malumbres M (2020) Mammalian cell cycle cyclins. Semin Cell Dev Biol 107:28\u201335","journal-title":"Semin Cell Dev Biol"},{"issue":"22","key":"1360_CR30","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1093\/nar\/gkaa1002","volume":"48","author":"S Hume","year":"2020","unstructured":"Hume S, Dianov GL, Ramadan K (2020) A unified model for the G1\/S cell cycle transition. Nucleic Acids Res 48(22):12483\u201312501","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1360_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17(9):528\u2013542","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1360_CR32","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1080\/15548627.2021.1912270","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, Yang KB, Chen W, Mai J, Wu XQ, Sun T, Wu RY et al (2021) CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy 17(12):4323\u20134340","journal-title":"Autophagy"},{"key":"1360_CR33","doi-asserted-by":"publisher","first-page":"100405","DOI":"10.1016\/j.jbc.2021.100405","volume":"296","author":"R Jia","year":"2021","unstructured":"Jia R, Bonifacino JS (2021) The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity. J Biol Chem 296:100405","journal-title":"J Biol Chem"},{"issue":"11","key":"1360_CR34","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1080\/15548627.2021.1897223","volume":"17","author":"W Wen","year":"2021","unstructured":"Wen W, Li X, Yin M, Wang H, Qin L, Li H, Liu W et al (2021) Selective autophagy receptor SQSTM1\/ p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3. Autophagy 17(11):3763\u20133775","journal-title":"Autophagy"},{"key":"1360_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","volume":"61","author":"PT Harrison","year":"2020","unstructured":"Harrison PT, Vyse S, Huang PH (2020) Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol 61:167\u2013179","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1360_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/cancers12061489","volume":"12","author":"S Belli","year":"2020","unstructured":"Belli S, Esposito D, Servetto A, Pesapane A, Formisano L, Bianco R (2020) c-Src and EGFR inhibition in molecular cancer therapy: what else can we improve? Cancers (Basel) 12(6):1489","journal-title":"Cancers (Basel)"},{"key":"1360_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ceb.2017.12.003","volume":"51","author":"Z Chen","year":"2018","unstructured":"Chen Z, Oh D, Dubey AK, Yao M, Yang B, Groves JT, Sheetz M (2018) EGFR family and src family kinase interactions: mechanics matters? Curr Opin Cell Biol 51:97\u2013102","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"1360_CR38","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/cancers12051087","volume":"12","author":"J Shen","year":"2020","unstructured":"Shen J, Li L, Howlett NG, Cohen PS, Sun G (2020) Application of a biphasic mathematical model of cancer cell drug response for formulating potent and synergistic targeted drug combinations to triple negative breast cancer cells. Cancers (Basel) 12(5):1087","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1360_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/15384101.2019.1568746","volume":"18","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang L, Meng L, Cao G, Wu Y (2019) Sirtuin 6 overexpression relieves sepsis-induced acute kidney injury by promoting autophagy. Cell Cycle 18(4):425\u2013436","journal-title":"Cell Cycle"},{"issue":"8","key":"1360_CR40","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.jmb.2019.10.028","volume":"432","author":"P L\u0151rincz","year":"2020","unstructured":"L\u0151rincz P, Juh\u00e1sz G (2020) Autophagosome-Lysosome Fusion. J Mol Biol 432(8):2462\u20132482","journal-title":"J Mol Biol"},{"issue":"5","key":"1360_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41556-021-00669-y","volume":"23","author":"C Chang","year":"2021","unstructured":"Chang C, Jensen LE, Hurley JH (2021) Autophagosome biogenesis comes out of the black box. Nat Cell Biol 23(5):450\u2013456","journal-title":"Nat Cell Biol"},{"issue":"11","key":"1360_CR42","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1080\/15548627.2020.1715047","volume":"16","author":"OA Mareninova","year":"2020","unstructured":"Mareninova OA, Jia W, Gretler SR, Holthaus CL, Thomas DDH, Pimienta M, Dillon DL et al (2020) Transgenic expression of GFP-LC3 perturbs autophagy in exocrine pancreas and acute pancreatitis responses in mice. Autophagy 16(11):2084\u20132097","journal-title":"Autophagy"},{"issue":"6","key":"1360_CR43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/15548627.2019.1659612","volume":"16","author":"G Salazar","year":"2020","unstructured":"Salazar G, Cullen A, Huang J, Zhao Y, Serino A, Hilenski L, Patrushev N et al (2020) SQSTM1\/p62 and PPARGC1A\/PGC-1alpha at the interface of autophagy and vascular senescence. Autophagy 16(6):1092\u20131110","journal-title":"Autophagy"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-023-01360-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T17:36:23Z","timestamp":1687541783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-023-01360-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s10637-023-01360-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}